The Beauty Health Company Reports Strong First Quarter 2022 Financial Results

Go back to The Beauty Health Company Reports Strong First Quarter 2022 Financial Results

The Beauty Health Company (SKIN) PT Lowered to $24 at Jefferies

May 11, 2022 8:25 AM EDT

Jefferies analyst Stephanie Wissink lowered the price target on The Beauty Health Company (NASDAQ: SKIN) to $24.00 (from $27.00) while maintaining a Buy rating following earnings.

The analyst commented, "Q1 sales +59% Y/Y driven by system sales +63% Y/Y were ahead of estimates & reflect strong... More

The Beauty Health Company (SKIN) PT Lowered to $20 at Cowen

May 11, 2022 8:04 AM EDT

Cowen analyst Oliver Chen lowered the price target on The Beauty Health Company (NASDAQ: SKIN) to $20.00 (from $27.00) while maintaining a Outperform rating following earnings.

The analyst commented, "We are encouraged by the early reception of Syndeo, but FY22 will be an investment... More

The Beauty Health Company (SKIN) Q1 Revenues Beats, Guides FY Revenues Higher

May 10, 2022 4:43 PM EDT

The Beauty Health Company (NASDAQ: SKIN) reported Q1 revenue of $75.4 million versus the consensus estimate of $68.37 million.

GUIDANCE:

The Beauty Health Company sees FY2022 revenue of $333-340 million, versus the consensus of $327.2 million.

For earnings history and earnings-related data on The Beauty Health Company (SKIN) click here.

... More